No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs370941784 |
chr12:42346090-42346091 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs546525680 |
chr12:42346094-42346095 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs564632494 |
chr12:42346119-42346120 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs531985165 |
chr12:42346183-42346184 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs189405575 |
chr12:42346234-42346235 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs140524370 |
chr12:42346266-42346267 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs12579100 |
chr12:42346318-42346319 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs547437826 |
chr12:42346409-42346410 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs193015073 |
chr12:42346420-42346421 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs536057350 |
chr12:42346456-42346457 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs527535032 |
chr12:42346469-42346470 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs552061989 |
chr12:42346472-42346473 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs150454359 |
chr12:42346492-42346493 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs537693971 |
chr12:42346519-42346520 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs79880576 |
chr12:42346619-42346620 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs138446391 |
chr12:42346625-42346626 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs143992495 |
chr12:42346627-42346628 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs535559573 |
chr12:42346667-42346668 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs553443046 |
chr12:42346684-42346685 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs572082515 |
chr12:42346718-42346719 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs185206785 |
chr12:42346752-42346753 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs147317894 |
chr12:42346843-42346844 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs1234025 |
chr12:42346846-42346847 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs370692518 |
chr12:42346864-42346865 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs139362991 |
chr12:42346892-42346893 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs189808056 |
chr12:42346895-42346896 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs531128090 |
chr12:42346910-42346911 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs115537775 |
chr12:42346928-42346929 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs149452780 |
chr12:42346931-42346932 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs115509717 |
chr12:42346936-42346937 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs143887082 |
chr12:42346937-42346938 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs552049465 |
chr12:42346979-42346980 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs148637138 |
chr12:42346985-42346986 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs531651280 |
chr12:42347045-42347046 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs549682272 |
chr12:42347054-42347055 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs565073698 |
chr12:42347083-42347084 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs528808260 |
chr12:42347097-42347098 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs535164293 |
chr12:42347135-42347136 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs547557643 |
chr12:42347138-42347139 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs375042621 |
chr12:42347139-42347140 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs565679256 |
chr12:42347153-42347154 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs546589154 |
chr12:42347183-42347184 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs181456384 |
chr12:42347250-42347251 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs532656666 |
chr12:42347271-42347272 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs558471937 |
chr12:42347296-42347297 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs576774140 |
chr12:42347300-42347301 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs537768168 |
chr12:42347308-42347309 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs555631483 |
chr12:42347351-42347352 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs1234026 |
chr12:42347363-42347364 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
50 |
rs554691607 |
chr12:42347372-42347373 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|